Availability and financing of CAR-T cell therapies: A cross-country comparative analysis

Yulia Litvinova, Sherry Merkur, Sara Allin, Ester Angulo-Pueyo, Daiga Behmane, Enrique Bernal-Delgado, Miriam Dalmas, Antonio De Belvis, Nigel Edwards, Francisco Estupiñán-Romero, Peter Gaal, Sophie Gerkens, Margaret Jamieson, Alisha Morsella, Dario Picecchi, Hilde Røshol, Ingrid Sperre Saunes, Terry Sullivan, Balázs Szécsényi-Nagy, Inneke Van De VijverRicciardi Walter, Dimitra Panteli

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalHealth Policy
Volume149
DOIs
Publication statusPublished - 2024

Keywords

  • Advanced Therapy Medicinal Products (ATMPs)
  • Cancer, Pharmaceutical policy
  • Chimeric antigen receptor (CAR) T-cell therapies
  • Oncology care

Cite this